医学
比例危险模型
腺癌
队列
内科学
对数秩检验
胃肠病学
外科
生存分析
阶段(地层学)
癌症
生物
古生物学
作者
James E. Lucocq,Jake Hawkyard,Francis P. Robertson,Beate Haugk,Jonathan Lye,Daniel Parkinson,Steve A. White,Omar A. Mownah,Yoh Zen,Krishna V Menon,Takaaki Furukawa,Yosuke Inoue,Yuki Hirose,Naoki Sasahira,Michael Feretis,Anita Balakrishnan,Piotr J. Zelga,Carlo D. L. Ceresa,Brian Ritchie Davidson,Rupaly Pandé
出处
期刊:Annals of Surgery
[Lippincott Williams & Wilkins]
日期:2023-10-24
卷期号:280 (1): 126-135
被引量:26
标识
DOI:10.1097/sla.0000000000006144
摘要
OBJECTIVE: This international multicenter cohort study aims to identify recurrence patterns and treatment of first and second recurrence in a large cohort of patients after pancreatic resection for adenocarcinoma arising from intraductal papillary mucinous neoplasm (IPMN). BACKGROUND: Recurrence patterns and treatment of recurrence postresection of adenocarcinoma arising from IPMN are poorly explored. METHODS: Patients undergoing pancreatic resection for adenocarcinoma from IPMN between January 2010 and December 2020 at 18 pancreatic centers were identified. Survival analysis was performed using the Kaplan-Meier log-rank test and multivariable logistic regression by Cox-Proportional Hazards modeling. End points were recurrence (time-to, location, and pattern of recurrence) and survival (overall survival and adjusted for treatment provided). RESULTS: Four hundred fifty-nine patients were included (median, 70 years; interquartile range, 64-76; male, 54%) with a median follow-up of 78.1 months. Recurrence occurred in 209 patients [45.5%; median time to recurrence, 12.8 months; early recurrence (within 1 years), 23.2%]. Eighty-three (18.1%) patients experienced a local regional recurrence, and 164 (35.7%) patients experienced a distant recurrence. Adjuvant chemotherapy was not associated with reduction in recurrence (hazard ratio 1.09; P =0.669) One hundred twenty patients with recurrence received further treatment. The median survival with and without additional treatment was 27.0 and 14.6 months ( P <0.001), with no significant difference between treatment modalities. There was no significant difference in survival between locations of recurrence ( P =0.401). CONCLUSIONS: Recurrence after pancreatic resection for adenocarcinoma arising from IPMN is frequent with a quarter of patients recurring within 12 months. Treatment of recurrence is associated with improved overall survival and should be considered.
科研通智能强力驱动
Strongly Powered by AbleSci AI